Tobacco Smoking and Nicotine Vaping in Persons with First Episode Psychosis

Tobacco smoking is highly prevalent in persons with psychosis and is the leading cause of preventable mortality in this population. Less is known about tobacco smoking in persons with first episode psychosis (FEP) and there have been no estimates about the prevalence of nicotine vaping in FEP. This study reports rates of tobacco smoking and nicotine vaping in young people with FEP enrolled in Coordinated Specialty Care programs in Pennsylvania and Maryland. Using data collected from 2021 to 2023, we examined lifetime and recent smoking and vaping and compared smokers and vapers to nonusers on symptoms, functioning, and substance use. The sample included 445 participants aged 13-35 with recent psychosis onset. Assessments were collected by program staff. Overall, 28 % of participants engaged in either smoking or vaping within 30 days of the admission assessment. Smokers and vapers were disproportionately male, cannabis users, and had lower negative symptom severity than non-smokers. Vapers had higher role and social functioning. Both smoking and vaping were related to a longer time from psychosis onset to program enrollment. We compare these findings to previous studies and suggest steps for addressing smoking and vaping in this vulnerable population.

References

Wagner E, McMahon L, Falkai P, Hasan A, Siskind D . Impact of smoking behavior on clozapine blood levels - a systematic review and meta-analysis. Acta Psychiatr Scand. 2020; 142(6):456-466. DOI: 10.1111/acps.13228. View

Bax O, Hakim N, Jeggo M, Phelan D, Stevens T, Gupta S . Improving smoking cessation in first episode psychosis: a quality improvement project by the City & Hackney Early and Quick Intervention Psychosis (EQUIP). BMJ Open Qual. 2020; 9(4). PMC: 7733214. DOI: 10.1136/bmjoq-2020-001002. View

Kristjansson A, Mann M, Sigfusdottir I . Licit and Illicit Substance Use by Adolescent E-Cigarette Users Compared with Conventional Cigarette Smokers, Dual Users, and Nonusers. J Adolesc Health. 2015; 57(5):562-4. DOI: 10.1016/j.jadohealth.2015.07.014. View

Liao W, Fan Y, Yang S, Li J, Duan X, Cui Q . Preservation Effect: Cigarette Smoking Acts on the Dynamic of Influences Among Unifying Neuropsychiatric Triple Networks in Schizophrenia. Schizophr Bull. 2018; 45(6):1242-1250. PMC: 6811814. DOI: 10.1093/schbul/sby184. View

Clarke M, Coughlin J . Prevalence of smoking among the lesbian, gay, bisexual, transsexual, transgender and queer (LGBTTQ) subpopulations in Toronto--the Toronto Rainbow Tobacco Survey (TRTS). Can J Public Health. 2012; 103(2):132-6. PMC: 6974290. View

Srihari V, Phutane V, Ozkan B, Chwastiak L, Ratliff J, Woods S . Cardiovascular mortality in schizophrenia: defining a critical period for prevention. Schizophr Res. 2013; 146(1-3):64-8. PMC: 3622848. DOI: 10.1016/j.schres.2013.01.014. View

Ren M, Lotfipour S . Nicotine Gateway Effects on Adolescent Substance Use. West J Emerg Med. 2019; 20(5):696-709. PMC: 6754186. DOI: 10.5811/westjem.2019.7.41661. View

Curtis J, Zhang C, McGuigan B, Pavel-Wood E, Morell R, Ward P . y-QUIT: Smoking Prevalence, Engagement, and Effectiveness of an Individualized Smoking Cessation Intervention in Youth With Severe Mental Illness. Front Psychiatry. 2019; 9:683. PMC: 6302018. DOI: 10.3389/fpsyt.2018.00683. View

Gurillo P, Jauhar S, Murray R, MacCabe J . Does tobacco use cause psychosis? Systematic review and meta-analysis. Lancet Psychiatry. 2015; 2(8):718-725. PMC: 4698800. DOI: 10.1016/S2215-0366(15)00152-2. View

10.

Fucito L, Bold K, Cannon S, Serrantino A, Marrero R, OMalley S . Cigarette Smoking in Response to COVID-19: Examining Co-Morbid Medical Conditions and Risk Perceptions. Int J Environ Res Public Health. 2022; 19(14). PMC: 9317071. DOI: 10.3390/ijerph19148239. View

11.

Misiak B, Kiejna A, Frydecka D . Assessment of cigarette smoking status with respect to symptomatic manifestation in first-episode schizophrenia patients. Compr Psychiatry. 2015; 58:146-51. DOI: 10.1016/j.comppsych.2014.11.024. View

12.

Fairchild A, Bayer R, Colgrove J . The renormalization of smoking? E-cigarettes and the tobacco "endgame". N Engl J Med. 2013; 370(4):293-5. DOI: 10.1056/NEJMp1313940. View

13.

Kelly D, McMahon R, Wehring H, Liu F, Mackowick K, Boggs D . Cigarette smoking and mortality risk in people with schizophrenia. Schizophr Bull. 2009; 37(4):832-8. PMC: 3122289. DOI: 10.1093/schbul/sbp152. View

14.

Dickerson F, Schroeder J, Katsafanas E, Khushalani S, Origoni A, Savage C . Cigarette Smoking by Patients With Serious Mental Illness, 1999-2016: An Increasing Disparity. Psychiatr Serv. 2017; 69(2):147-153. DOI: 10.1176/appi.ps.201700118. View

15.

Graham A, Cha S, Papandonatos G, Amato M, Jacobs M, Abroms L . E-cigarette and combusted tobacco abstinence among young adults: Secondary analyses from a U.S.-based randomized controlled trial of vaping cessation. Prev Med. 2022; 165(Pt B):107119. DOI: 10.1016/j.ypmed.2022.107119. View

16.

Harris P, Taylor R, Thielke R, Payne J, Gonzalez N, Conde J . Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2008; 42(2):377-81. PMC: 2700030. DOI: 10.1016/j.jbi.2008.08.010. View

17.

Romm K, Cohn A, Wang Y, Berg C . Psychosocial predictors of trajectories of dual cigarette and e-cigarette use among young adults in the US. Addict Behav. 2023; 141:107658. PMC: 10154740. DOI: 10.1016/j.addbeh.2023.107658. View

18.

Sanchez-Gutierrez T, Rodriguez-Toscano E, Roldan L, Ferraro L, Parellada M, Calvo A . Tobacco use in first-episode psychosis, a multinational EU-GEI study. Psychol Med. 2023; 53(15):7265-7276. DOI: 10.1017/S0033291723000806. View

19.

Cornblatt B, Auther A, Niendam T, Smith C, Zinberg J, Bearden C . Preliminary findings for two new measures of social and role functioning in the prodromal phase of schizophrenia. Schizophr Bull. 2007; 33(3):688-702. PMC: 2526147. DOI: 10.1093/schbul/sbm029. View

20.

Dickerson F, Origoni A, Rowe K, Katsafanas E, Newman T, Ziemann R . Risk factors for natural cause mortality in a cohort of 1494 persons with serious mental illness. Psychiatry Res. 2021; 298:113755. DOI: 10.1016/j.psychres.2021.113755. View